These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39033022)

  • 1. Frequency and clinicopathologic features of renal low-grade oncocytic tumour and eosinophilic vacuolated tumour: reclassification of 605 eosinophilic tumours including patients managed with active surveillance.
    Choiniere R; Al Qa'qa' S; Cheung CC; Finelli A; Prendeville S
    J Clin Pathol; 2024 Jul; ():. PubMed ID: 39033022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do we need an updated classification of oncocytic renal tumors? : Emergence of low-grade oncocytic tumor (LOT) and eosinophilic vacuolated tumor (EVT) as novel renal entities.
    Hes O; Trpkov K
    Mod Pathol; 2022 Sep; 35(9):1140-1150. PubMed ID: 35273336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LOT and HOT … or not. The proliferation of clinically insignificant and poorly characterised types of renal neoplasia.
    Samaratunga H; Egevad L; Thunders M; Iczskowski KA; van der Kwast T; Kristiansen G; Pan CC; Leite KRM; Evans A; Clouston D; Kenwright DN; Bethwaite PB; Malone G; Wood S; Yaxley JW; Delahunt B
    Pathology; 2022 Dec; 54(7):842-847. PubMed ID: 36270849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics.
    Kravtsov O; Gupta S; Cheville JC; Sukov WR; Rowsey R; Herrera-Hernandez LP; Lohse CM; Knudson R; Leibovich BC; Jimenez RE
    Hum Pathol; 2021 Aug; 114():9-18. PubMed ID: 33961838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-grade oncocytic tumour (LOT) of the kidney is characterised by GATA3 positivity, FOXI1 negativity and mTOR pathway mutations.
    Chen T; Peng Y; Lei T; Wu C; Wang H; Shi Y
    Pathol Oncol Res; 2023; 29():1610852. PubMed ID: 36816543
    [No Abstract]   [Full Text] [Related]  

  • 6. Algorithm-Based Approach to the Histological Routine Diagnosis of Renal Oncocytic Tumors in Core Biopsy Specimens.
    Manini C; Imaz I; de Larrinoa AF; López JI
    Curr Urol Rep; 2022 Nov; 23(11):327-333. PubMed ID: 36169870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
    Almutairi F; Xu B
    Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a distinct low-grade oncocytic renal tumor (CD117-negative and cytokeratin 7-positive) based on a tertiary oncology center experience: the new evidence from China.
    Guo Q; Liu N; Wang F; Guo Y; Yang B; Cao Z; Wang Y; Wang Y; Zhang W; Huang Q; Zhao W; Liu C; Qu T; Li L; Cao L; Ren D; Meng B; Qi L; Wang C; Cao W
    Virchows Arch; 2021 Mar; 478(3):449-458. PubMed ID: 32918598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.
    Ricci C; Ambrosi F; Franceschini T; Giunchi F; Grillini A; Franchini E; Grillini M; Schiavina R; Massari F; Mollica V; Tateo V; Bianchi FM; Bianchi L; Droghetti M; Maloberti T; Tallini G; Colecchia M; Acosta AM; Lobo J; Trpkov K; Fiorentino M; de Biase D
    Virchows Arch; 2023 Nov; 483(5):687-698. PubMed ID: 37845471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real world outcomes of biopsy-proven oncocytic neoplasm of the kidney managed by surveillance.
    Rodger FE; Brown K; Leung S; Coode-Bate J; Armitage J; Warren A; Hendry J; Stewart GD; Laird A; Oades GM
    BJUI Compass; 2022 Jul; 3(4):291-297. PubMed ID: 35783590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acceptance of emerging renal oncocytic neoplasms: a survey of urologic pathologists.
    Mohanty SK; Lobo A; Jha S; Sangoi AR; Akgul M; Trpkov K; Hes O; Mehra R; Hirsch MS; Moch H; Smith SC; Shah RB; Cheng L; Amin MB; Epstein JI; Parwani AV; Delahunt B; Desai S; Przybycin CG; Manini C; Luthringer DJ; Sirohi D; Jain D; Midha D; Jain E; Maclean F; Giannico GA; Paner GP; Martignoni G; Al-Ahmadie HA; McKenney J; Srigley JR; Lopez JI; Kunju LP; Browning L; Aron M; Picken MM; Tretiakova M; Zhou M; Sable M; Kuroda N; Pattnaik N; Gupta NS; Rao P; Fine SW; Mishra P; Adhya AK; Kulkarni BN; Dixit M; Baisakh MR; Arora S; Sancheti S; Menon S; Wobker SE; Tickoo SK; Kaushal S; Soni S; Kandukuri S; Sharma S; Mitra S; Reuter VE; Malik V; Rao V; Chen YB; Williamson SR
    Virchows Arch; 2024 Nov; 485(5):829-840. PubMed ID: 39287823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TSC/mTOR Pathway Mutation Associated Eosinophilic/Oncocytic Renal Neoplasms: A Heterogeneous Group of Tumors with Distinct Morphology, Immunohistochemical Profile, and Similar Genetic Background.
    Pivovarcikova K; Alaghehbandan R; Vanecek T; Ohashi R; Pitra T; Hes O
    Biomedicines; 2022 Jan; 10(2):. PubMed ID: 35203531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eosinophilic vacuolated tumor (EVT) of kidney demonstrates sporadic TSC/MTOR mutations: next-generation sequencing multi-institutional study of 19 cases.
    Farcaş M; Gatalica Z; Trpkov K; Swensen J; Zhou M; Alaghehbandan R; Williamson SR; Magi-Galluzzi C; Gill AJ; Tretiakova M; Lopez JI; Montiel DP; Sperga M; Comperat E; Brimo F; Yilmaz A; Siadat F; Sangoi A; Gao Y; Ptákova N; Kuthi L; Pivovarcikova K; Rogala J; Agaimy A; Hartmann A; Fraune C; Rychly B; Hurnik P; Durcansky D; Bonert M; Gakis G; Michal M; Hora M; Hes O
    Mod Pathol; 2022 Mar; 35(3):344-351. PubMed ID: 34521993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-Grade Oncocytic Tumor: Report of Two Cases of An Emerging Entity in the Spectrum of Oncocytic Renal Neoplasms.
    Sharma D; Pai T; Prakash G; Desai S; Menon S
    Turk Patoloji Derg; 2022; 38(2):162-166. PubMed ID: 34514579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-grade oncocytic tumour of the kidney is characterised by genetic alterations of TSC1, TSC2, MTOR or PIK3CA and consistent GATA3 positivity.
    Williamson SR; Hes O; Trpkov K; Aggarwal A; Satapathy A; Mishra S; Sharma S; Sangoi A; Cheng L; Akgul M; Idrees M; Levin A; Sadasivan S; San Miguel Fraile P; Rogala J; Comperat E; Berney DM; Bulimbasic S; McKenney JK; Jha S; Sampat NY; Mohanty SK
    Histopathology; 2023 Jan; 82(2):296-304. PubMed ID: 36208048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade oncocytic tumor of kidney harboring TSC/MTOR mutation: clinicopathologic, immunohistochemical and molecular characteristics support a distinct entity.
    Zhang HZ; Xia QY; Wang SY; Shi MJ; Wang SY
    Virchows Arch; 2022 May; 480(5):999-1008. PubMed ID: 35099634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-grade oncocytic tumour of kidney (CD117-negative, cytokeratin 7-positive): a distinct entity?
    Trpkov K; Williamson SR; Gao Y; Martinek P; Cheng L; Sangoi AR; Yilmaz A; Wang C; San Miguel Fraile P; Perez Montiel DM; Bulimbasić S; Rogala J; Hes O
    Histopathology; 2019 Aug; 75(2):174-184. PubMed ID: 30895640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-grade oncocytic tumour expands the spectrum of renal oncocytic tumours and deserves separate classification: a review of 23 cases from a single tertiary institute.
    Akgul M; Al-Obaidy KI; Cheng L; Idrees MT
    J Clin Pathol; 2022 Nov; 75(11):772-775. PubMed ID: 34168073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Low-Grade Oncocytic Tumor/Chromophobe Renal Cell Carcinoma (Oncocytic Variant) of the Kidney.
    Ishikawa N; Kimura N; Yoshida T; Yoshimura I; Nakahara K; Tsuzuki T; Tokunaga O
    Case Rep Pathol; 2021; 2021():6684777. PubMed ID: 33680526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinicopathological features of low-grade oncocytic renal tumor (CD117-negative, cytokeratin 7-positive): report of seven cases].
    Xie B; Cheng LC; Yin GL; Liu BA; Hu ZL; Tong K
    Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):719-725. PubMed ID: 35922161
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.